13F HOLDINGS REPORT
NEA Management Company, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001012975-24-000337
Total Value
$1.33B
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 3,745,262 | $206.7M | 15.55% |
| 2 | TEMPUS AI INC | TEM | 4,572,810 | $160.0M | 12.04% |
| 3 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,909,956 | $119.5M | 8.99% |
| 4 | SAVARA INC | SVRA | 24,471,264 | $98.6M | 7.42% |
| 5 | COURSERA INC | COUR | 12,867,769 | $92.1M | 6.93% |
| 6 | CRISPR THERAPEUTICS AG | CRSP | 1,587,854 | $85.8M | 6.45% |
| 7 | VERONA PHARMA PLC | 925050106 | 5,584,753 | $80.8M | 6.08% |
| 8 | NEXTNAV INC | NXNVW | 8,189,156 | $66.4M | 5.00% |
| 9 | KORRO BIO INC | KRRO | 1,090,793 | $36.9M | 2.78% |
| 10 | TREVI THERAPEUTICS INC | TRVI | 11,370,376 | $33.9M | 2.55% |
| 11 | MONTE ROSA THERAPEUTICS INC | GLUE | 7,692,298 | $28.8M | 2.16% |
| 12 | CVRX INC | CVRX | 2,370,542 | $28.4M | 2.14% |
| 13 | AURINIA PHARMACEUTICALS INC | AUPH | 3,969,834 | $22.7M | 1.71% |
| 14 | NKARTA INC | NKTX | 3,568,781 | $21.1M | 1.59% |
| 15 | BLACK DIAMOND THERAPEUTICS INC | BDTX | 4,448,757 | $20.7M | 1.56% |
| 16 | CELCUITY INC | CELC | 1,250,001 | $20.5M | 1.54% |
| 17 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,960,169 | $20.2M | 1.52% |
| 18 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 17,079,778 | $16.7M | 1.25% |
| 19 | GOSSAMER BIO INC | GOSS | 18,093,034 | $16.3M | 1.23% |
| 20 | NEUEHEALTH INC | 10920V404 | 2,726,917 | $14.8M | 1.12% |
| 21 | GERON CORP | GERN | 2,776,409 | $11.8M | 0.89% |
| 22 | REGULUS THERAPEUTICS INC | 75915K200 | 6,467,802 | $11.6M | 0.87% |
| 23 | INOZYME PHARMA INC | 45790W108 | 2,437,689 | $10.9M | 0.82% |
| 24 | ORIC PHARMACEUTICALS INC | ORIC | 1,500,000 | $10.6M | 0.80% |
| 25 | BUZZFEED INC | BZFDW | 3,833,473 | $10.6M | 0.80% |
| 26 | MYND AI INC | MYND | 3,642,711 | $10.1M | 0.76% |
| 27 | CHAMPIONS ONCOLOGY INC | CSBR | 1,713,720 | $8.9M | 0.67% |
| 28 | X4 PHARMACEUTICALS INC | XFOR | 14,986,793 | $8.7M | 0.65% |
| 29 | RENEO PHARMACEUTICALS INC | 75974E103 | 4,785,494 | $7.2M | 0.54% |
| 30 | SAGIMET BIOSCIENCES INC | SGMT | 2,000,275 | $6.8M | 0.51% |
| 31 | ALLAKOS INC | 01671P100 | 6,147,260 | $6.1M | 0.46% |
| 32 | DESKTOP METAL INC | 25058X303 | 1,439,892 | $5.9M | 0.45% |
| 33 | MARKER THERAPEUTICS INC | MRKR | 1,071,428 | $5.8M | 0.44% |
| 34 | TUYA INC | TUYA | 3,260,976 | $5.6M | 0.42% |
| 35 | SYNLOGIC INC | SYBX | 2,922,772 | $4.4M | 0.33% |
| 36 | INVENTIVA SA | IVEVF | 1,462,586 | $4.4M | 0.33% |
| 37 | LEXICON PHARMACEUTICALS INC | LXRX | 2,382,286 | $4.0M | 0.30% |
| 38 | AFFIMED NV | N01045207 | 442,649 | $2.4M | 0.18% |
| 39 | SENTI BIOSCIENCES INC | SNTI | 4,426,151 | $1.2M | 0.09% |
| 40 | IKENA ONCOLOGY INC | 45175G108 | 570,050 | $940,583 | 0.07% |
| 41 | WHEELS UP EXPERIENCE INC | WSUPW | 106,125 | $200,576 | 0.02% |